Article
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in…
medRxiv · 2023 · Gedik, M. E.; Saatci, O.; Oberholtzer, N.; Uner, M.; Akbulut, O.; Cetin, M.; Aras, M.; Ibis, K.; Caliskan, B.; Banoglu, E.; Wiemann, S.; Uner, A.; Aksoy, S.; Mehrotra, S.; Sahin, O.
Key facts
| Title | Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer |
|---|---|
| First author | Gedik, M. E.; Saatci, O.; Oberholtzer, N.; Uner, M.; Akbulut, O.; Cetin, M.; Aras, M.; Ibis, K.; Caliskan, B.; Banoglu, E.; Wiemann, S.; Uner, A.; Aksoy, S.; Mehrotra, S.; Sahin, O. |
| Journal | medRxiv |
| Published | Sep 14, 2023 |
| DOI | 10.1101/2023.09.12.557273 |
| Devices mentioned | 217137 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1